DEXCOM INC Stockholders' Equity 2008-2026 | DXCM
Beta
What is stockholders' equity?
Stockholders' equity can be defined as total assets minus total liabilities, representing the owners' residual interest in the company after all debts are paid.
What is DEXCOM INC's current stockholders' equity?
DEXCOM INC (DXCM) annual stockholders' equity for 2025 was $2.75B, a 30.60% increase from 2024. DEXCOM INC stockholders' equity for the quarter ending March 31, 2026 was $2.96B.
What was DEXCOM INC's stockholders' equity in 2024?
DEXCOM INC annual stockholders' equity for 2024 was $2.10B, a 1.64% increase from 2023.
What was DEXCOM INC's stockholders' equity in 2023?
DEXCOM INC annual stockholders' equity for 2023 was $2.07B, a 2.96% decline from 2022.
What is DEXCOM INC's 5-year stockholders' equity CAGR?
DEXCOM INC stockholders' equity grew at a compound annual growth rate (CAGR) of 8.50% from FY2020 to FY2025, going from $1.83B to $2.75B over 5 years.
Stockholders' Equity History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+8.5%
FY2020
$1.83B
→
FY2025
$2.75B
080910111213141516171819202122232425
5 years selected
Stockholders' Equity History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.75B | +30.6% | 10-K |
| FY2024 | $2.10B | +1.6% | 10-K |
| FY2023 | $2.07B | -3.0% | 10-K |
| FY2022 | $2.13B | +4.4% | 10-K |
| FY2021 | $2.04B | +11.8% | 10-K |
| FY2020 | $1.83B | +106.9% | 10-K |
| FY2019 | $882.6M | +33.1% | 10-K |
| FY2018 | $663.3M | +58.2% | 10-K |
| FY2017 | $419.4M | +47.8% | 10-K |
| FY2016 | $283.8M | +28.3% | 10-K |
| FY2015 | $221.2M | +57.8% | 10-K |
| FY2014 | $140.2M | +66.7% | 10-K |
| FY2013 | $84.1M | +9.2% | 10-K |
| FY2012 | $77.0M | -26.3% | 10-K |
| FY2011 | $104.5M | +71.3% | 10-K |
| FY2010 | $61.0M | +431.5% | 10-K |
| FY2009 | $-18.4M | +5.5% | 10-K |
| FY2008 | $-19.5M | - | 10-K |
Company: DEXCOM INCTicker: DXCMSector: HealthcareIndustry: Surgical & Medical Instruments & ApparatusView company profile →